Legence Inc (LGN)

Legence Inc. is a common stock listing on the NASDAQ exchange. The company provides engineering, installation, and maintenance services for mission-critical building systems across the United States. Its operations are organized into two segments: Engineering & Consulting and Installation & Maintenance. The Engineering & Consulting segment focuses on designing HVAC and other mechanical, electrical, and plumbing systems, along with energy-efficiency and sustainability planning, program management, and project oversight for installation and retrofit work. The Installation & Maintenance segment handles the fabrication and installation of HVAC, process piping, and related systems, as well as preventive maintenance, emergency repairs, facility energy analysis, automation, optimization, and testing services. Legence serves customers in data centers, technology, life sciences, healthcare, education, mixed-use, and government markets. Founded in 1914, the company is based in San Jose, California.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-LGN
$63.25
-11.6% Downside
Fair
$106.94
49.5% Upside
Undervalued
Good
0.0%
September 2, 2026
1,570.2x
15.3x
2.5x
7.362 B
6.891 B
13.1%
74.6%
3.7
8,462.7%
Valuation • Fair Value

Legence Inc (NASDAQ-LGN) Fair Value by Valuation Model

Compare the primary fair value estimate for Legence Inc (NASDAQ-LGN) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$63.25

Estimated downside of 11.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$70.02

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.51

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$56.48

Comparable-company valuation reference.

Analyst Price Target

$106.94

Analysts imply upside of 49.5%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Legence Inc (NASDAQ-LGN) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Legence Inc (NASDAQ-LGN)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

3.082 B

Current operating scale indicator.

Revenue Forecast

4.27 B

Forward revenue estimate.

EBITDA

238.9 M

Current operating profitability reference.

EBITDA Forecast

485.1 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Legence Inc (NASDAQ-LGN) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Legence Inc (NASDAQ-LGN)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

4

Mid-range quality score.

Beneish M-Score

-2.16

Intermediate zone that deserves monitoring.

Altman Z-Score

3.7

Relatively strong balance-sheet zone.

FCF / Net Income

8,462.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Legence Inc (NASDAQ-LGN). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Legence Inc (NASDAQ-LGN)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 2, 2026

Days to Earnings

43

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Legence Inc (NASDAQ-LGN), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Legence Inc (NASDAQ-LGN) Stock Forecast & Technical Outlook

Review Legence Inc (NASDAQ-LGN) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Legence Inc (NASDAQ-LGN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Legence Inc (NASDAQ-LGN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Legence Inc (NASDAQ-LGN) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Legence Inc (NASDAQ-LGN) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Legence Inc (NASDAQ-LGN) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Legence Inc (NASDAQ-LGN)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Legence Inc (NASDAQ-LGN) has a Strong Buy consensus, with 14 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 14
Hold 1
Sell 0
FAQ Fast Investor Answers

Legence Inc (NASDAQ-LGN) Stock FAQ

Quick answers about Legence Inc (NASDAQ-LGN) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$63.25
Estimated downside 11.6%
Valuation Rating
Overvalued
Estimated downside of 11.6%
Analyst Target
$106.94
Implied upside 49.5%
Financial Health
Good
Current financial-health read

The current fair value estimate for Legence Inc (NASDAQ-LGN) is $63.25. This implies an estimated downside of 11.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 11.6% versus the current market price.

The available analyst price target for Legence Inc (NASDAQ-LGN) is $106.94. The analyst target implies estimated upside of 49.5%.

The current financial health read for Legence Inc (NASDAQ-LGN) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Legence Inc (NASDAQ-LGN) is September 2, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Legence Inc (NASDAQ-LGN) is 1,570.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Legence Inc is 7.362 B.

The current enterprise value listed for Legence Inc is 6.891 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Legence Inc is NASDAQ-LGN, and the stock is listed on NASDAQ.

Legence Inc (NASDAQ-LGN) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Legence Inc is 13.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Legence Inc is 74.6%. Free float helps investors understand how much of the share base is available for public trading.